Orphan Drugs Industry Advisory & Intelligence
Skip to content
Home
About us
Free demo
ODI Advisory
ODI Insider | Oncology
ODI Insider | Rare Diseases
ODI | Databases
Press, Articles & News
Big (bio)pharma involvement and orphan diseases: reality or “orphan-washing”? Part 2 – The Pfizer case
Posted on
May 2, 2016
by
christian@orphandrugsindustry.com
Link to article
Advertisements
Posted in
Pulse
|
Tagged
Big pharma
,
Orphan drugs
,
Rare diseases
Big (bio)pharma involvement and orphan diseases: reality or “orphan-washing”? Part 1 – The Novartis case
Posted on
April 26, 2016
by
christian@orphandrugsindustry.com
Link to article
Posted in
Pulse
|
Tagged
Big pharma
,
Orphan drugs
,
Rare diseases
Advertisements
Search for:
Archives
May 2016
April 2016
Meta
Register
Log in
Click to contact us
Visitors
3,196 hits
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here:
Our Cookie Policy
